Ownership history in UBS Group AG · 4 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in INMED PHARMACEUTICALS INC (INM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 377 | -7,385 | -95.1% | 0.00% | $400 | $1.06 |
| 2025 Q2 | ADDED | 7,762 | +1,656 | +27.1% | 0.00% | $25K | $3.25 |
| 2025 Q1 | REDUCED | 6,106 | -4,302 | -41.3% | 0.00% | $13K | $2.07 |
| 2024 Q4 | INITIATED | 10,408 | — | — | 0.00% | $49K | $4.74 |
As of 2025 Q4 — sorted by position size